The price of the 2023 Chrysler Voyager starts at $37,090. Chrysler makes the decision easy. There's only one model, but it ...
Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 - - Sharpened focus on multi-modality pipeline with ...
Single dose of TRACER AAV vector encoding anti-HER2 antibody reduced CNS tumor burden and extended survival across multiple mouse models of breast cancer brain metastasis Novel AAV5-derived capsid ...
LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report ...
- Voyager to receive up-front consideration of $175 million including a $39 million equity investment, up to $1.5 billion in potential development milestones, additional potential commercial ...
Results presented at the American Society of Gene and Cell Therapy 25th Annual Meeting CAMBRIDGE, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy ...
--Voyager Therapeutics, Inc., a biotechnology company dedicated to advancing neurogenetic medicines, today reported fourth quarter and full year 2023 financial and operating results. “As of December ...
VOYG] will host its third quarter 2025 earnings results conference call Tuesday, Nov. 4, 2025, at 9 a.m. ET with the senior management team. Third quarter 2025 results will be published after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback